A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone. - Leblond, Véronique; Morel, Pierre; Dilhuidy, Marie-Sarah; Leleu, Xavier; Soussain, Carole; Leprête, Stéphane; Dreyfus, Brigitte; Dartigeas, Caroline; Mahé, Béatrice; Anglaret, Bruno; Pégourié, Brigitte; Besson, Caroline; et al. (Leukemia & Lymphoma, 2017)